Literature DB >> 3594717

The effect of dietary amino acids on the gastrointestinal absorption of melphalan and chlorambucil.

C G Adair, J C McElnay.   

Abstract

Previous studies have demonstrated that the bioavailability of melphalan and chlorambucil may be reduced under non-fasting conditions, and that the gastrointestinal and cellular absorption of melphalan is an active process, while that of chlorambucil is passive. In view of these findings, the effect of dietary amino acids on the gastrointestinal absorption of these two drugs was investigated using the in situ rat intestine model. The segment lengths used in the study were (mean +/- SD) 47.1 +/- 3.8 cm. Experimentation was carried out in a randomised fashion and involved monitoring the absorption of drug from control intestinal segments and from segments perfused with L-glycine (1 and 10 mM) and L-leucine (1 and 10 mM). For chlorambucil, absorption was carried out from segments perfused with the 10 mM concentration of amino acids only. Aliquots of gut-perfusing solution were removed at 5-min intervals over 30 min and assayed for drug content using a high-performance liquid chromatography (HPLC) method which was selective for each agent. Values recorded for the absorption of melphalan were (mean +/- SD percentage absorption per centimetre segment length over a 30-min period) 1.11% +/- 0.07% cm-1 (control); 1.18% +/- 0.20% cm-1 (1 mM L-glycine); 0.99% +/- 0.27% cm-1 (1 mM L-leucine); 0.80% +/- 0.25% cm-1 (10 mM L-glycine); and 0.60% +/- 0.23% cm-1 (10 mM L-leucine). Chlorambucil absorption from control animals was 1.77% +/- 0.11% cm-1 gut length, as against 1.77% +/- 0.08% cm-1 in 10 mM L-glycine and 1.69% +/- 0.16% cm-1 in 10 mM-L-leucine-perfused segments. The only statistically significant observation was a reduction in melphalan absorption from perfusate containing 10 mM leucine (P less than 0.005). The experimental data suggest that competitive inhibition by amino acids may be one of the mechanisms involved in the observed reduction in melphalan bioavailability under non-fasting conditions, but that it has no effect on chlorambucil absorption.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3594717     DOI: 10.1007/bf00261486

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  19 in total

Review 1.  Influence of food and diet on gastrointestinal drug absorption: a review.

Authors:  P G Welling
Journal:  J Pharmacokinet Biopharm       Date:  1977-08

2.  Studies on the transport and cellular distribution of chlorambucil in the Yoshida ascites sarcoma.

Authors:  B T Hill
Journal:  Biochem Pharmacol       Date:  1972-02-15       Impact factor: 5.858

3.  Evidence for carrier-mediated transport of melphalan by L5178Y lymphoblasts in vitro.

Authors:  G J Goldenberg; M Lee; H Y Lam; A Begleiter
Journal:  Cancer Res       Date:  1977-03       Impact factor: 12.701

4.  Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro.

Authors:  G J Goldenberg; H Y Lam; A Begleiter
Journal:  J Biol Chem       Date:  1979-02-25       Impact factor: 5.157

5.  The pharmacokinetics of melphalan in patients with multiple myeloma: an intravenous/oral study using a conventional dose regimen.

Authors:  K W Woodhouse; P Hamilton; A Lennard; M D Rawlins
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

6.  Amino acid-conferred resistance to melphalan. I. Structure-activity relationship in cultured murine L1210 leukemia cells.

Authors:  D T Vistica; J N Toal; M Rabinovitz
Journal:  Cancer Treat Rep       Date:  1976-09

7.  Comparison of the fed and fasting states on the absorption of melphalan in multiple myeloma.

Authors:  A G Bosanquet; E D Gilby
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

8.  Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma.

Authors:  A G Bosanquet; E D Gilby
Journal:  Eur J Cancer Clin Oncol       Date:  1982-04

9.  Uptake and decomposition of chlorambucil by L5178Y lymphoblasts in vitro.

Authors:  A Begleiter; G J Goldenberg
Journal:  Biochem Pharmacol       Date:  1983-02-01       Impact factor: 5.858

10.  Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil.

Authors:  C G Adair; J C McElnay
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

View more
  3 in total

Review 1.  Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy.

Authors:  Brahma N Singh; Bimal K Malhotra
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  The role of diet on the clinical pharmacology of oral antineoplastic agents.

Authors:  Antonio Ruggiero; Maria G Cefalo; Paola Coccia; Stefano Mastrangelo; Palma Maurizi; Riccardo Riccardi
Journal:  Eur J Clin Pharmacol       Date:  2011-07-28       Impact factor: 2.953

Review 3.  Interaction between cytostatics and nutrients.

Authors:  R Henriksson; K O Rogo; K Grankvist
Journal:  Med Oncol Tumor Pharmacother       Date:  1991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.